K. Thapaliya, A. Sweeting, K. I. Black, A. Poprzeczny, D. Mazza, L. E. Grzeskowiak, “Incidence of GLP-1 Receptor Agonist Use by Women of Reproductive Age Attending General Practices in Australia, 2011–2022: A Retrospective Open Cohort Study,” Medical Journal of Australia 223, no. 7 (2025): 365–371, https://onlinelibrary.wiley.com/doi/10.5694/mja2.70026
In Box 4, the y-axis should read ‘Proportion (%)’, as shown below:
Box 4. Proportion of women aged 18–49 years who conceived within 6months of the first prescribing of glucagon-like peptide-1 (GLP-1) receptor agonists, 2011–2022, by type 2 diabetes status.
Correspondence:
Online responses are no longer available. Please refer to our instructions for authors page for more information.